AUTACs: Cargo-Specific Degraders Using Selective Autophagy
- PMID: 31606272
- DOI: 10.1016/j.molcel.2019.09.009
AUTACs: Cargo-Specific Degraders Using Selective Autophagy
Abstract
Protein silencing represents an essential tool in biomedical research. Targeted protein degradation (TPD) strategies exemplified by PROTACs are rapidly emerging as modalities in drug discovery. However, the scope of current TPD techniques is limited because many intracellular materials are not substrates of proteasomal clearance. Here, we described a novel targeted-clearance strategy (autophagy-targeting chimera [AUTAC]) that contains a degradation tag (guanine derivatives) and a warhead to provide target specificity. As expected from the substrate scope of autophagy, AUTAC degraded fragmented mitochondria as well as proteins. Mitochondria-targeted AUTAC accelerated both the removal of dysfunctional fragmented mitochondria and the biogenesis of functionally normal mitochondria in patient-derived fibroblast cells. Cytoprotective effects against acute mitochondrial injuries were also seen. Canonical autophagy is viewed as a nonselective bulk decomposition system, and none of the available autophagy-inducing agents exhibit useful cargo selectivity. With its target specificity, AUTAC provides a new modality for research on autophagy-based drugs.
Keywords: AUTAC; Down syndrome; K63-linked polyubiquitin; PROTACs; S-guanylation; autophagy; cargo-specific degrader; drug discovery; mitophagy; targeted protein degradation.
Copyright © 2019 Elsevier Inc. All rights reserved.
Similar articles
-
Targeting selective autophagy by AUTAC degraders.Autophagy. 2020 Apr;16(4):765-766. doi: 10.1080/15548627.2020.1718362. Epub 2020 Jan 20. Autophagy. 2020. PMID: 31958028 Free PMC article.
-
[Protein induced proximity and targeted degradations by new degraders: concepts, developments, challenges for clinical applications].Biol Aujourdhui. 2024;218(1-2):41-54. doi: 10.1051/jbio/2024007. Epub 2024 Jul 15. Biol Aujourdhui. 2024. PMID: 39007776 Review. French.
-
Novel approaches to targeted protein degradation technologies in drug discovery.Expert Opin Drug Discov. 2023 Apr;18(4):467-483. doi: 10.1080/17460441.2023.2187777. Epub 2023 Mar 9. Expert Opin Drug Discov. 2023. PMID: 36895136 Free PMC article. Review.
-
Redefining the Scope of Targeted Protein Degradation: Translational Opportunities in Hijacking the Autophagy-Lysosome Pathway.Biochemistry. 2023 Feb 7;62(3):580-587. doi: 10.1021/acs.biochem.1c00330. Epub 2021 Sep 27. Biochemistry. 2023. PMID: 34569233 Review.
-
Targeted Protein Degradation via Lysosomes.Biochemistry. 2023 Feb 7;62(3):564-579. doi: 10.1021/acs.biochem.2c00310. Epub 2022 Sep 21. Biochemistry. 2023. PMID: 36130224 Free PMC article. Review.
Cited by
-
Mitophagy in Human Diseases.Int J Mol Sci. 2021 Apr 9;22(8):3903. doi: 10.3390/ijms22083903. Int J Mol Sci. 2021. PMID: 33918863 Free PMC article. Review.
-
The mechanisms and roles of selective autophagy in mammals.Nat Rev Mol Cell Biol. 2023 Mar;24(3):167-185. doi: 10.1038/s41580-022-00542-2. Epub 2022 Oct 27. Nat Rev Mol Cell Biol. 2023. PMID: 36302887 Review.
-
Targeted protein degradation using the lysosomal pathway.RSC Med Chem. 2022 Oct 13;13(12):1476-1494. doi: 10.1039/d2md00273f. eCollection 2022 Dec 14. RSC Med Chem. 2022. PMID: 36561077 Free PMC article. Review.
-
Endo-Lysosomal and Autophagy Pathway and Ubiquitin-Proteasome System in Mood Disorders: A Review Article.Neuropsychiatr Dis Treat. 2023 Jan 14;19:133-151. doi: 10.2147/NDT.S376380. eCollection 2023. Neuropsychiatr Dis Treat. 2023. PMID: 36684613 Free PMC article. Review.
-
The AUTOTAC chemical biology platform for targeted protein degradation via the autophagy-lysosome system.Nat Commun. 2022 Feb 16;13(1):904. doi: 10.1038/s41467-022-28520-4. Nat Commun. 2022. PMID: 35173167 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous